Log In
BCIQ
Print this Print this
 

Eporatio, Ratioepo, Biosimilar epoetin theta

Also known as: epoetin theta

  Manage Alerts
Collapse Summary General Information
Company Teva Pharmaceutical Industries Ltd.
DescriptionBiosimilar of epoetin theta
Molecular Target
Mechanism of ActionBiosimilar
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationAnemia
Indication DetailsTreat anemia associated with chronic kidney disease (CKD) and to treat treat anemia associated with chronic renal failure and in patients with non-myeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy; Treat cancer treatment-associated anemia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today